300858 科拓生物
按盤價 
19.790 +0.550 (+2.859%)
19.790 +0.550 (+2.859%) | 2025/06 - 中期 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.301 | 5.357 | 5.451 | 8.250 | 11.531 |
| 總資產報酬率 ROA (%) | 2.135 | 5.065 | 5.191 | 7.760 | 10.739 |
| 投入資產回報率 ROIC (%) | 2.268 | 5.268 | 5.361 | 8.085 | 11.344 | 邊際利潤分析 |
| 銷售毛利率 (%) | 49.239 | 58.252 | 54.582 | 51.975 | 50.313 |
| 營業利潤率 (%) | 30.532 | 36.151 | 34.287 | 34.558 | 34.201 |
| 息稅前利潤/營業總收入 (%) | 24.444 | 27.858 | 26.262 | 33.175 | 32.338 |
| 淨利潤/營業總收入 (%) | 25.226 | 31.162 | 31.239 | 29.767 | 30.042 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 87.086 | 83.943 | 87.848 | 89.411 | 77.507 |
| 價值變動淨收益/利潤總額(%) | 4.521 | 5.138 | 7.237 | 7.433 | 10.599 |
| 營業外收支淨額/利潤總額(%) | 0.019 | -0.583 | -0.549 | -1.529 | -0.427 | 償債能力分析 |
| 流動比率 (X) | 8.316 | 9.925 | 16.296 | 15.560 | 12.046 |
| 速動比率 (X) | 7.961 | 9.441 | 15.627 | 14.963 | 11.200 |
| 資產負債率 (%) | 7.838 | 6.579 | 4.259 | 5.308 | 7.046 |
| 帶息債務/全部投入資本 (%) | -0.209 | -0.080 | 0.737 | 0.966 | 1.715 |
| 股東權益/帶息債務 (%) | -47,151.644 | -122,902.593 | 13,323.437 | 10,189.120 | 5,668.954 |
| 股東權益/負債合計 (%) | 1,175.794 | 1,419.955 | 2,247.741 | 1,783.798 | 1,319.193 |
| 利息保障倍數 (X) | -4.011 | -3.446 | -3.350 | -38.431 | -18.825 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 69.174 | 72.447 | 101.453 | 106.466 | 115.992 |
| 存貨周轉天數 (天) | 98.420 | 122.204 | 119.403 | 105.367 | 96.953 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 28/08/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
